Aducanumab reduces Aβ plaques in Alzheimer's disease

Mov Disord. 2016 Nov;31(11):1631. doi: 10.1002/mds.26833. Epub 2016 Oct 14.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Plaque, Amyloid*

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • aducanumab